BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33386400)

  • 1. Equity and economic evaluation of system-level health interventions: A case study of Brazil's Family Health Program.
    Love-Koh J; Mirelman A; Suhrcke M
    Health Policy Plan; 2021 Apr; 36(3):229-238. PubMed ID: 33386400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.
    Meunier A; Longworth L; Gomes M; Ramagopalan S; Garrison LP; Popat S
    Pharmacoeconomics; 2023 Aug; 41(8):1011-1025. PubMed ID: 37296369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distributional impact of the Malawian Essential Health Package.
    Arnold M; Nkhoma D; Griffin S
    Health Policy Plan; 2020 Jul; 35(6):646-656. PubMed ID: 32361730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions.
    Yang F; Duarte A; Walker S; Griffin S
    Med Decis Making; 2021 Aug; 41(6):653-666. PubMed ID: 34098791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.
    Love-Koh J; Cookson R; Gutacker N; Patton T; Griffin S
    Value Health; 2019 May; 22(5):518-526. PubMed ID: 31104729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis.
    Kowal S; Ng CD; Schuldt R; Sheinson D; Cookson R
    Value Health; 2023 Feb; 26(2):216-225. PubMed ID: 36192293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Intervention Impact on Health Inequality for Resource Allocation.
    Griffin S; Love-Koh J; Pennington B; Owen L
    Med Decis Making; 2019 Apr; 39(3):171-182. PubMed ID: 30819034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.
    Ward T; Mujica-Mota RE; Spencer AE; Medina-Lara A
    Pharmacoeconomics; 2022 Jan; 40(1):45-64. PubMed ID: 34713423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distributional Cost-Effectiveness Analysis: A Tutorial.
    Asaria M; Griffin S; Cookson R
    Med Decis Making; 2016 Jan; 36(1):8-19. PubMed ID: 25908564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distributional impact of infectious disease interventions in the Ethiopian Essential Health Service Package: a modelling study.
    Assebe LF; Norheim O
    BMJ Open; 2023 Jul; 13(7):e067658. PubMed ID: 37460265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How health inequalities accumulate and combine to affect treatment value: A distributional cost-effectiveness analysis of smoking cessation interventions.
    Love-Koh J; Pennington B; Owen L; Taylor M; Griffin S
    Soc Sci Med; 2020 Nov; 265():113339. PubMed ID: 33039733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis.
    Yang F; Angus C; Duarte A; Gillespie D; Walker S; Griffin S
    Med Decis Making; 2020 Jul; 40(5):606-618. PubMed ID: 32608317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic model of community-based falls prevention: seeking methodological solutions in evaluating the efficiency and equity of UK guideline recommendations.
    Kwon J; Squires H; Young T
    BMC Geriatr; 2023 Mar; 23(1):187. PubMed ID: 36997884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.
    Meunier A; Opeifa O; Longworth L; Cox O; Bührer C; Durand-Zaleski I; Kelly SP; Gale RP
    Eye (Lond); 2024 Mar; ():. PubMed ID: 38555401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing regional health inequality: a sub-national distributional cost-effectiveness analysis of community-based treatment of childhood pneumonia in Ethiopia.
    Olsen M; Norheim OF; Memirie ST
    Int J Equity Health; 2021 Jan; 20(1):9. PubMed ID: 33407559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration.
    Killedar A; Lung T; Taylor RW; Hayes A
    Appl Health Econ Health Policy; 2023 Jul; 21(4):615-625. PubMed ID: 37221341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
    Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
    Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Housing improvements for health and associated socio-economic outcomes.
    Thomson H; Thomas S; Sellstrom E; Petticrew M
    Cochrane Database Syst Rev; 2013 Feb; (2):CD008657. PubMed ID: 23450585
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.